BARCELONA, SPAIN and GERRARDS CROSS, BUCKS, UK – 26 July, 2011 – Veeva Systems announced today that Daiichi Sankyo, one …

For the past decade prolongation of the QT interval has been used by the regulatory agencies as the principal biomarker …
European regulators have recommended the approval of a new, once-daily form of Boehringer Ingelheim’s HIV treatment Viramune. Viramune (nevirapine) has …

The FDA has refused to file Eisai’s epilepsy drug perampanel, saying it needs more information for the treatment. The FDA …
Udit Batra is to join Merck KGaA as head of its consumer health care division on 1 September. He moves …
Specialist pharma company Shire has posted exceptionally strong results for the second quarter, increasing its product sales by 30% and …
GlaxoSmithKline chief executive Andrew Witty has promised to expand operations in the UK in both manufacturing and R&D, saying that …
Julia Holt has joined Red Door Communications from Apothecom Huntsworth Health as an associate director and member of the management …
A quartet of former employees at LeapFrog have banded together to launch a new UK med comms agency. Bamboo Medical …

Sanofi’s acquisition of Genzyme helped its revenue grow in the second quarter, but underlying growth from the French firm disappointed. …
New data shows that prescription sales increased by more than two-thirds in England over the last decade, but a majority …
Dr David-Alexandre Gros has joined Sanofi as chief strategy officer with a remit that covers all the group’s business development …

Lilly has released details of its payments to doctors and healthcare organisations in the US. The company paid $48.1 million …

Sir John Oldham is not widely known outside the Department of Health, but he might just have the most difficult …

GlaxoSmithKline has posted a slide in revenue for the second quarter, but is buoyed by strong underlying growth. Sales were …

NICE has recommended Celgene’s thalidomide ahead of J&J’s Velcade for multiple myeloma. Celgene’s drug is recommended in combination with an …
PPD plays down sell-off rumours, Icon sees a steep profit decline, plus updates from Beaufort, PharmaNet, ClinStar and Biofocus/IMD. PPD …
New UK comms agency Open Health has strengthened its management team, appointing three new partners. Andy Bell, Cory Inglis and …

GlaxoSmithKline has been drawn further into concerns about contamination of pharmaceuticals, foods and beverages with plasticiser compounds, after authorities in …
NICE has launched a consultation in the UK on a new medical procedure which, if it proves safe and effective, …